Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

OBUTIN TABLETS 5 mg

Approval Number

SIN11215P

Drug Name

OBUTIN TABLETS 5 mg

Product Name

OBUTIN TABLETS 5 mg

Approval Date

November 4, 1999

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

G04BD04

ATC Item Name

oxybutynin

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

HANLIM PHARMACEUTICAL CO LTD

Active Ingredients

Ingredient Name

OXYBUTYNIN CHLORIDE

Strength

5 mg

Drug MonographOxybutynin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy